On Friday, SeaWorld Entertainment Inc (NYSE:SEAS)’s shares declined -0.17% to $18.06.
The Board of Directors of SeaWorld Entertainment, Inc. (SEAS) declared a cash dividend of $0.21 per share of common stock. The dividend is payable on October 6, 2015 to shareholders of record at the close of business on September 29, 2015.
SeaWorld Entertainment, Inc. operates as a theme park and entertainment company in the United States. The company operates marine-life theme park under the SeaWorld brand name in Orlando, San Antonio, and San Diego; Busch Gardens theme parks, which are family-oriented destinations with foreign geographic settings in Tampa and Williamsburg; Discovery Cove marine-life theme park in Langhorne; and Sesame Place, a seasonal park in Langhorne.
3D Systems Corporation (NYSE:DDD)’s shares dropped -1.70% to $12.17.
3D Systems (DDD) declared that it will be taking part in Euromold, one of the world’s leading trade shows for moldmaking and tooling, in addition to 3D printing, which will be held this year in Dusseldorf, Germany, September 22-25.
3DS will showcase its wide range of software and 3D printing solutions, counting CimatronE, GibbsCAM(R) and Geomagic(R) software suites, in addition to its 3D printers and Quickparts cloud-based manufacturing services.
3DS is unique in its ability to offer integrated engineering solutions that encompass the entire spectrum of the digital thread for manufacturing, counting scanning, design, production and inspection. This combination of tools brings together both additive and traditional technologies, resulting in improved productivity and greatly improved interoperability.
3D Systems Corporation, through its auxiliaries, operates as a provider of 3D printing centric design-to-manufacturing solutions in the Americas, Germany, and the Asia-Pacific, in addition to other European, the Middle East, and African countries.
At the end of Friday’s trade, Galena Biopharma Inc (NASDAQ:GALE)‘s shares dipped -8.33% to $1.65.
Galena Biopharma, Inc. (GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, recently declared that data from the Company’s Phase 2a portion of the Phase 1/2a clinical trial of GALE-301, or Folate Binding Protein, will be presented at the forthcoming European Society for Medical Oncology (ESMO) European Cancer Congress 2015 in Vienna, Austria.
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs across cancer care.
Parsley Energy Inc (NYSE:PE), ended its Friday’s trading session with -3.30% loss, and closed at $14.64.
Parsley Energy, Inc. (PE) declared that it will take part in the Johnson Rice 2015 Energy Conference in New Orleans on Tuesday, September 29, during which Bryan Sheffield, Chairman and Chief Executive Officer, is planned to make a presentation. Investor slides will be posted in association with this presentation and can be accessed on the Investor Relations section of Parsley’s website at www.parsleyenergy.com.
Parsley Energy, Inc., an independent oil and natural gas company, engages in the acquisition, development, production, exploration, and sale of crude oil and natural gas properties in the Permian Basin located in West Texas and Southeastern New Mexico. As of December 31, 2014, its acreage position comprised of 133,274 net acres, counting 103,036 net acres in the Midland Basin and 30,238 net acres in the Delaware Basin; and estimated proved oil and natural gas reserves were 90.9 MMBoe.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
